No Data
Rodman & Renshaw Initiates Telomir Pharmaceuticals(TELO.US) With Buy Rating, Announces Target Price $15
Telomir Pharmaceuticals Initiated With a Buy at Rodman & Renshaw
Express News | Telomir Pharmaceuticals Achieves Breakthrough In Silver Ion Stabilization, Says Unlocking A New Multi-Billion Dollar Medical Market
Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration
Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
Express News | Telomir Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing
DJMA : thanks for sharing. positive to see several that I am already holding at a good price, hoping for a positive start to the week.
70592820 : Confirmation means chasing up.
Jaguar8 OP 70592820 : ????
70592820 Jaguar8 OP : 15.1$
Jaguar8 OP 70592820 : I don’t know what you are talking about. Sorry
View more comments...